We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
2626
Viking Therapeutics
VKTX
$4B
$63K ﹤0.01%
10,583
-86,592
-89% -$514K
POL
2627
DELISTED
Polished.com Inc.
POL
$59K ﹤0.01%
+309
New +$84.5K
TNXP icon
2628
Tonix Pharmaceuticals
TNXP
$192M
0
EGIO
2629
DELISTED
Edgio, Inc. Common Stock
EGIO
$58K ﹤0.01%
459
-10
-2% -$1.32K
CECO icon
2630
Ceco Environmental
CECO
$4.14B
$57K ﹤0.01%
7,988
+48
+0.6% +$371
NCMI icon
2631
National CineMedia
NCMI
$378M
$56K ﹤0.01%
1,108
-1,435
-56% -$67.3K
LFVN icon
2632
LifeVantage
LFVN
$85.3M
$55K ﹤0.01%
7,429
+2,349
+46% +$19.2K
RNAC icon
2633
Cartesian Therapeutics
RNAC
$268M
$53K ﹤0.01%
422
-17
-4% -$2.02K
SCOR icon
2634
Comscore
SCOR
$109M
$50K ﹤0.01%
+502
New +$39.4K
EPM icon
2635
Evolution Petroleum
EPM
$131M
$49K ﹤0.01%
9,890
LXRX icon
2636
Lexicon Pharmaceuticals
LXRX
$1.1B
$49K ﹤0.01%
10,693
+578
+6% +$2.78K
AVTX icon
2637
Avalo Therapeutics
AVTX
$983M
$48K ﹤0.01%
5
DRRX
2638
DELISTED
DURECT Corp
DRRX
$48K ﹤0.01%
2,938
-89
-3% -$1.55K
AMPE
2639
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$48K ﹤0.01%
97
-3
-3% -$1.61K
SLDB icon
2640
Solid Biosciences
SLDB
$900M
$47K ﹤0.01%
+857
New +$56.6K
STON
2641
DELISTED
StoneMor Inc.
STON
$47K ﹤0.01%
17,844
-540
-3% -$1.23K
BKCC
2642
DELISTED
BlackRock Capital Investment Corporation
BKCC
$46K ﹤0.01%
11,685
-413
-3% -$1.63K
NBEV
2643
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$45K ﹤0.01%
20,279
-833
-4% -$1.94K
ADVM
2644
DELISTED
Adverum Biotechnologies
ADVM
$44K ﹤0.01%
1,250
-9,544
-88% -$514K
FBIO icon
2645
Fortress Biotech
FBIO
$88.7M
$43K ﹤0.01%
797
+46
+6% +$2.77K
LTRPA
2646
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$43K ﹤0.01%
10,593
+150
+1% +$728
TRVN
2647
DELISTED
Trevena, Inc.
TRVN
$42K ﹤0.01%
40
NMTR
2648
DELISTED
9 Meters Biopharma
NMTR
$42K ﹤0.01%
1,921
+335
+21% +$8.22K
LITS
2649
Lite Strategy Inc
LITS
$30.9M
$41K ﹤0.01%
719
-76
-10% -$4.88K
SEEL
2650
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$41K ﹤0.01%
4
+1
+33% +$16.4K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.